ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,384, issued on April 21, was assigned to INTRA-CELLULAR THERAPIES INC. (Bedminster, N.J.).
"Uses" was invented by David Kass (New York), Toru Hashimoto (New York), Lawrence P. Wennogle (Hillsborough, N.J.), Joseph Hendrick (New York) and Robert Davis (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides methods, treatments and materials for enhancing the effect of an adenosine A2 receptor agonist in the treatment, mitigation or prophylaxis of a disease or condition characterized by inotropic and/or lusitropic dysfunction, and/or enhancing adenosine A2 receptor function in the treatment, mitigation or prophylaxis of a dis...